KRAS mutations are the most frequent oncogenic driver mutations in human lung cancer cells (Cancer Genome Atlas Research, 2014; Jordan et al., 2017; Skoulidis et al., 2015). The gene discussed is KRAS; the disease is lung carcinoma.